Food is a topic that is both deeply personal and of global importance. What we eat affects our health and longevity, but also the lives of animals and the future of our planet.
New technologies and scientific discoveries are now enabling us to transform how we produce food and personalize nutrition in entirely new ways.
In this episode, Andreas Horchler and Louise von Stechow speak with food expert and CEO of Berlin Food Campus, Lia Carlucci, about key trends shaping the future of food—from alternative proteins to personalized nutrition.
You can find Lia here: https://www.linkedin.com/in/lia-carlucci-foodtech-entrepreneur-ceo-speaker/?originalSubdomain=de
And Berlin Food campus here: https://www.foodcampus.berlin/
Disclaimer:
Louise von Stechow & Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast.
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
scientific communication: https://science-tales.com/
Podcasts: https://www.podcon.de/
Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow
Image: Markus Spiske via Unsplash
--------
41:45
--------
41:45
The biorevolution podcast #35
Despite great hopes for Artificial Intelligence (AI) in biotech and pharma—with investments exceeding $50 billion over the past ten years—the question of when the technology will reach maturity remains difficult to answer. How can biotech and pharma leaders navigate this complex gray area, where hype around the technology obscures the outlook and few concrete milestones provide clear signposts for decision-making?
In this episode of the BioRevolution podcast, Louise von Stechow and Andreas Horchler speak with their guest, idalab founder Paul von Bünau, about the potential of AI in biotech. They explore how leaders can adapt internal processes, support their teams in facing the challenges AI brings, and examine whether AI has the potential to make us better leaders.
Find Dr. Paul von Bünau here: https://www.linkedin.com/in/paulvonbuenau/
and idalab here: https://idalab.de/
Disclaimer:
Louise von Stechow & Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast.
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
scientific communication: https://science-tales.com/
Podcasts: https://www.podcon.de/
Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow
Image: Matteo Vistocco via Unsplash
--------
41:15
--------
41:15
The biorevolution podcast #34
More than 20 years after the Human Genome Project, enabled by new sequencing technologies, researchers are making progress in exploring the vast non-coding space that constitutes 98% of our genomes. This non-coding, or "dark," DNA harbors elements with important regulatory functions in health and disease. But pinpointing disease-relevant DNA elements within this massive DNA space can be like searching for a needle in a haystack. This difficult search can be eased by artificial intelligence (AI)-based tools, which predict the context-dependent relevance of certain DNA elements and highlight their role in different diseases, from cancer to rare neurodegenerative disorders.
For Episode 33 of the BioRevolution podcast, Andreas Horchler and Louise von Stechow are joined by CTO and co-founder of Berlin-based biotech LUCID Genomics, Dr. Hossein Moeinzadeh, to discuss the exciting field of non-coding DNA and how LUCID’s AI algorithm can help make sense of non-coding DNA — and how this could improve diagnoses of rare diseases and beyond.
Learn more about LUCID genomics AI tool here: https://www.lucid-genomics.com/technology
Find Dr. Hossein Moeinzadeh here: https://www.linkedin.com/in/mhossein-moeinzadeh/
Disclaimer:
Louise von Stechow & Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast.
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
scientific communication: https://science-tales.com/
Podcasts: https://www.podcon.de/
Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow
Image:
via Unsplash.
--------
38:11
--------
38:11
The biorevolution podcast #33
When the Swiss chemist synthesized and tested the psychedelic compound LSD in the 1930s, he knew he had found a tool to explore the human mind.
Indeed, before psychedelics became illegal in the late 1960s, a mountain of evidence had been produced, showing potential benefits of psychedelic-assisted therapy for depression, anxiety, and substance abuse.
After a decades-long hiatus, research on psychedelics as a treatment for psychiatric diseases is experiencing a renaissance—and initial results look promising.
While the field has seen a setback with the recent request for more data by the FDA for the approval of MDMA for PTSD, research into different psychedelic compounds continues, promising new hopes to battle worldwide mental health crises.
In the newest episode of the BioRevolution podcast, Andreas Horchler and Louise von Stechow discuss the history, the promise, and the risks of psychedelics as treatments for psychiatric diseases with neuroscientist, psychedelics expert, and executive coach Galyna Pidpruzhnykova
https://www.linkedin.com/in/galynapidpruzhnykova/
https://www.galynapipdpruzhnykova.com/
Galyna also outlines her efforts to develop a psychedelics strategy to battle the mental health crisis in Ukraine, where the Ministry of Health published a draft law for research on psychedelic compounds just a few days after we recorded this podcast.
https://www.linkedin.com/feed/update/urn:li:activity:7308180815761330176/
Disclaimer:
Louise von Stechow & Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast.
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
scientific communication: https://science-tales.com/
Podcasts: https://www.podcon.de/
Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow
--------
42:21
--------
42:21
The biorevolution podcast #32
This time on the BioRevolution podcast: science itself.
While recent surveys show persistently high trust in science worldwide, certain scientific topics have become the subject of intense societal and political debate. This politicization of science puts scientists in a difficult position when they are trying to argue based on facts.
The value of facts and evidence-based science seems to be increasingly questioned by those in power and by those in control of assets. If those who make laws and regulate science don’t see evidence and consensus as reliable resources anymore, what will become of progress in biomedicine, which feeds innovation in biotech, pharma, and medicine?
Disclaimer:
Louise von Stechow & Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast.
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
scientific communication: https://science-tales.com/
Podcasts: https://www.podcon.de/
Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow
Image:
via Photoshop AI.
Further reading:
https://nsf-gov-resources.nsf.gov/2023-04/EndlessFrontier75th_w.pdf
https://www.nature.com/articles/s41562-024-02090-5
https://www.nature.com/articles/s41599-024-03909-2
https://www.pewresearch.org/science/2024/11/14/public-trust-in-scientists-and-views-on-their-role-in-policymaking/?utm_source=chatgpt.com
https://www.nature.com/articles/d41586-025-00525-1
https://pmc.ncbi.nlm.nih.gov/articles/PMC8793038/
https://www.wissenschaftskommunikation.de/wie-lange-vertraut-man-uns-noch-83325/
https://www.nopatientleftbehind.org/defending-the-foundation-of-american-science
https://theweek.com/science/distrust-science-politics-2024-public-trust-vaccines-milk-pandemic
https://pmc.ncbi.nlm.nih.gov/articles/PMC11004618/
https://www.nature.com/articles/d41586-024-00238-x
https://www.forbes.com/sites/innovationrx/2025/02/19/innovationrx-recursion-launches-fund-for-biotech-startups-hit-by-nih-funding-cuts/
The Biorevolution Podcast with Andreas Horchler and Louise von Stechow – father and daughter, journalist and biologist, talking about the technologies of the biorevolution. Can genetic engineering, synthetic biology, and artificial intelligence save humanity from disease, climate change, and overpopulation, or are these technologies the first step towards its downfall?
Content and Editing:
Louise von Stechow and Andreas Horchler
Disclaimer:
Louise von Stechow, Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics but do not claim to give medical, investment, or life advice in the podcast.
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
scientific communication: https://science-tales.com/
Podcasts: https://www.podcon.de/
Image: Kelly Sikkema via Unsplash
Netherlands